𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Essential language function of the right hemisphere in brain tumor patients

✍ Scribed by Alexander Thiel; Birgit Habedank; Lutz Winhuisen; Karl Herholz; Josef Kessler; Walter F. Haupt; Wolf-Dieter Heiss


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
96 KB
Volume
57
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Neuroimaging studies of language networks in patients with brain lesions of the left language‐dominant hemisphere have shown activation in the right inferior frontal gyrus (IFG). We tested the functional relevance of right IFG activation using neuroimaging‐guided repetitive transcranial magnetic stimulation (rTMS) to disturb language function over bilateral IFG in right‐handed patients with brain tumors and controls. All subjects were susceptible to TMS over the left IFG. In patients, this susceptibility correlated with left‐sided the degree of language lateralization to the left. Those patients with lowest dominance were also susceptible to right‐sided TMS proving relevant language function of the right IFG. Ann Neurol 2005;57:128–131


📜 SIMILAR VOLUMES


False positive images in the follow-up o
✍ Moghrabi, Albert; Tien, Robert; Fuchs, Herbert; Longee, Darell; McLendon, Roger; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

In recent years, major advances in the diagno-new enhancing lesions on MRI following treatsis and treatment of patients with brain tumors ment of their tumors with surgery (3 patients), have been seen. Today, evaluation of the central chemotherapy (2 patients), and radiotherapy (2 nervous system alm

Safety and efficacy of a multicenter stu
✍ Nancy D. Doolittle; Michael E. Miner; Walter A. Hall; Tali Siegal; E. Jerome Han 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 2 views

The aim of this study was to determine the safety and efficacy of intraarterial chemotherapy with osmotic opening of the blood-brain barrier (BBB) for the treatment of malignant brain tumors when administered across multiple centers.